Eupraxia Pharmaceuticals Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
11.33 |
19.49 |
17.35 |
51.96 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
71.96% |
-10.97% |
199.41% |
| Przychód (min) |
0.00 |
0.00 |
11.33 |
19.34 |
17.35 |
51.96 |
| Przychód (max) |
0.00 |
0.00 |
11.33 |
19.64 |
17.35 |
51.96 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-15.49 |
-17.29 |
-19.76 |
-4.69 |
-23.06 |
-8.21 |
| Zysk netto % |
-inf% |
-inf% |
-174.32% |
-24.07% |
-132.90% |
-15.80% |
| EPS (średnia) |
-0.64 |
-0.72 |
-0.78 |
-0.63 |
-0.96 |
-0.34 |
| Liczba analityków (Przychody) |
0 |
0 |
3 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
2 |
3 |
6 |
6 |
3 |
4 |
| symbol |
EPRX |
EPRX |
EPRX |
EPRX |
EPRX |
EPRX |